Dionex Acquires Swift Monolithic LC Media Technology
News Sep 01, 2005
Dionex Corporation has announced the acquisition of the SWIFT™ monolithic liquid chromatography media products, intellectual property, technology and other related assets from Teledyne Isco, Inc. (a subsidiary of Teledyne Technologies Incorporated) in an all-cash transaction.
According to Dionex, this deal expands and strengthens Dionex' polymer bead-based separation media technology platform for ion chromatography and HPLC, and designed to enable the Company to enter liquid chromatography applications in nano-, capillary-, analytical- and preparative flow formats.
"Monolithic separation media have received increasing interest from customers in our key markets, as this novel technology allows for higher resolution and faster separation at much lower backpressures," said Lukas Braunschweiler, President and Chief Executive Officer of Dionex Corporation.
"The acquisition of the SWIFT™ monolithic media technology enables our Company to address new applications in small- and bio-molecule ion chromatography and HPLC separations, to answer the needs of our customers to have faster separations, and to continue to lead the trend towards smaller formats, system integration and miniaturization."
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE